RxSight, Inc. to Present at the Needham Virtual Healthcare Conference

ALISO VIEJO, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming Needham Virtual Healthcare Conference.

RxSight’s management is scheduled to present Monday, April 11, 2022, at 12:45pm PT / 3:45pm ET. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.rxsight.com/.

About RxSight, Inc.
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight^® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens^® (LAL^®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The LAL now features ActivShield™ technology, a revolutionary UV protection layer built into the lens. Additional information about RxSight can be found at www.rxsight.com.

Investor Relations Contact:
Philip Taylor
Gilmartin Group
415.937.5406
[email protected]

Company Contact:
Shelley Thunen
RxSight, Inc.
949-521-7830
[email protected]

You May Also Be Interested In

• Malaga Financial Corporation Announces 89th Consecutive Quarterly Cash Dividend
• NEW YORK CAR DEALERS REMEMBER 9/11 - HOW THEY CAME TOGETHER FOR NEW YORK
• American Rebel Light Beer Invites Patriotic Music Fans to Black Oak Amphitheater Tonight for Big & Rich-Headlined 9/11 Tribute Honoring First Responders and America's Military